NCT07492095 Leucine Requirements in School-Age Children
| NCT ID | NCT07492095 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of British Columbia |
| Condition | Nutrient Intake |
| Study Type | INTERVENTIONAL |
| Enrollment | 7 participants |
| Start Date | 2026-06-25 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 7 participants in total. It began in 2026-06-25 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Leucine is an essential amino acid, which serves a special purpose of signaling cell growth in muscle in addition to making up protein. Essential amino acids like leucine need to be eaten every day from our foods like meat, dairy, eggs, beans, and nuts, as they cannot be made by our bodies. The current recommendation for leucine in the diet of school-age children are based upon adult needs. This study will measure the leucine requirement in children aged 6-10 years old using an non-invasive technique with special diets, safe stable isotopes, and simple breath collections. Creating guidelines based on measured requirements for leucine in this age group is essential for supporting optimal growth in healthy children.
Eligibility Criteria
Inclusion Criteria: * Healthy children * Aged 6 to 10 years at enrollment * Body weight between the 3rd and 85th percentile according to WHO Child Growth Standards * Assent from the child and written informed consent from parent(s) and/or legal guardian(s) Exclusion Criteria: * Diagnosis of any acute or chronic medical condition * Current use of prescription medication that may affect protein or energy metabolism * Recent weight loss * Recent illness (fever, vomiting, severe runny nose within the past 5 days) * Inability to comply with study procedures
Contact & Investigator
Rajavel Elango
PRINCIPAL INVESTIGATOR
University of British Columbia
Frequently Asked Questions
Who can join the NCT07492095 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 10 Years, studying Nutrient Intake. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07492095 currently recruiting?
Yes, NCT07492095 is actively recruiting participants. Contact the research team at kendall.plant@bcchr.ca for enrollment information.
Where is the NCT07492095 trial being conducted?
This trial is being conducted at Vancouver, Canada.
Who is sponsoring the NCT07492095 clinical trial?
NCT07492095 is sponsored by University of British Columbia. The principal investigator is Rajavel Elango at University of British Columbia. The trial plans to enroll 7 participants.